HIGH

Zydus Lifesciences Chlorpromazine Hydrochloride 100 mg Recall 2025

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets, 100 mg, 100-count bottles distributed nationwide in the USA for Northstar Rx LLC, Memphis, TN 38141, are recalled. The recall cites CGMP deviations with the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake. Healthcare providers and patients should stop using the product immediately and contact the manufacturer or a医

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Zydus Lifesciences, Northstar Rx LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Chlorpromazine hydrochloride is an antipsychotic used to treat schizophrenia and other psychiatric conditions. It is a prescription medication in the United States. The recalled product was manufactured in India for Northstar Rx LLC.

Why This Is Dangerous

The hazard arises from CGMP deviations leading to nitrosamine impurity exposure. Nitrosamines have been linked to cancer risk with long-term exposure.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

If exposed to the impurity, patients may face potential cancer risk. Immediate cessation of use is advised and medical guidance should be sought.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 16714-050-01 on the bottle label.
  2. Inspect lot numbers Z305456, Z401156, Z407306 on the bottle.
  3. Confirm distribution by Northstar Rx LLC nationwide in the USA.

Where to find product info

FDA recall page: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0637-2025

What timeline to expect

Not specified in the recall notice.

If the manufacturer is unresponsive

  • Escalate to FDA MedWatch or your clinician for guidance.
  • Consider filing a recall report with the FDA.

How to prevent similar issues

  • Verify NDC numbers before obtaining prescribed medications.
  • Consult your healthcare provider before switching or stopping a prescribed drug.
  • Use medications from verified manufacturers and pharmacies.

Documentation advice

Keep the recall notice, bottle label, NDC, and lot numbers. Document communications with healthcare providers and manufacturers.

Product Details

Product: Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle (Rx only). Manufacturer: Zydus Lifesciences Ltd., Baddi, India. Manufactured for: Northstar Rx LLC, Memphis, TN 38141. NDC: 16714-050-01. Lot numbers: Z305456; Z401156; Z407306. Sold nationwide in the USA. Recall date: 2025-09-03. Status: Active. Hazard level: HIGH. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • NDC 16714-050-01
  • Lot numbers Z305456, Z401156, Z407306
  • Manufactured in India for Northstar Rx LLC
  • Distributed Nationwide in the USA
  • Recall date 2025-09-03
  • Status Active

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONINGOTHER

Product Classification

Product Details

Model Numbers
Z305456
Z401156
Z407306
UPC Codes
16714-047
16714-048
16714-049
+7 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more